Latest Post

Synopsis : FabiSpray is a Nitric Oxide Nasal Spray (NONS) designed to kill the COVID-19 virus in the upper airways. It has proven anti-microbial properties with a direct virucidal effect …

Summary : The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for bebtelovimab, an antibody that demonstrates neutralization against the Omicron variant, Eli Lilly and …

It’s uncertain if we will ever determine the origins of COVID-19. The current top theories split about evenly between a lab leak from the Wuhan Institute of Virology and a natural …

It is not uncommon for different countries to require at least part of a clinical trial be conducted in their country. The rationale is not nationalistic, but rather, ethnicity-oriented in …

Uppsala researchers have succeeded in designing a molecule that inhibits the replication of coronaviruses and that has great potential for development into a drug suitable for treating COVID-19. The molecule …

Summary : Drug firm Lupin on Wednesday said it has entered into a distribution pact with Slovenia-based Medis for its orphan drug NaMuscla. As part of the agreement, Medis will …

Summary : Consumer protection regulator CCPA has passed an order against GlaxoSmithKline (GSK) Consumer Healthcare Ltd directing it to discontinue advertisements of Sensodyne products in India for flouting norms. The …

Synopsis : An investment consortium led by Signet Healthcare Partners, Bionpharma, Inc and GMS Capital Partners LLC today announced it has formed Pharma Nobis, LLC to acquire Fagron’s US contract …

Summary : The life science group Sartorius announced today that, through its subgroup Sartorius Stedim Biotech, it closed the acquisition of the Novasep chromatography division as of February 7, 2022, …

Summary : Sanofi announced the completion of its acquisition of Amunix Pharmaceuticals, Inc, adding a promising pipeline of T-cell engagers and cytokine therapies. The acquisition also provides access to Amunix …

Summary : Amgen has posted a 3% rise in total 2021 fourth-quarter revenues to $6.8 billion and a 2% increase in total revenue for the year to $26 billion, driven mainly through wins from …

Summary : Pfizer Chief Executive Officer Albert Bourla called 2021 a watershed year for the company. It posted $81.3 billion in revenue driven by sales of its COVID-19 vaccine, Comirnaty, …

Synopsis : Alzheon today posted positive results from its Phase II biomarker trial on ALZ-801 (valiltramiprosate) in patients diagnosed with neurodegenerative disorders such as Alzheimer’s disease. ALZ-801 is administered orally …

Summary : Samsung Biologics, the world’s leading contract development and manufacturing organization (CDMO), announced that it has been selected as a winner of the 2022 CMO Leadership Awards presented by …

Why some patients develop metastases and others do not is largely unclear. Researchers around ISTA professor Daria Siekhaus are now contributing to a better understanding of the process in certain …

Summary – A study by Virginia Commonwealth University Massey Cancer Center researchers published in today’s print edition of Molecular Cancer Therapeutics shows that triplatin is effective against triple negative breast …

Avalo Therapeutics, Inc. (Nasdaq: AVTX), a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology and rare genetic …

Summary : Biogen Inc. (Nasdaq: BIIB) and Xbrane Biopharma AB (STO: XBRANE) today announced that they have entered into a commercialization and license agreement to develop, manufacture, and commercialize Xcimzane™, …

Summary : Home BancShares, Inc. (NYSE: HOMB) (“Home” or the “Company”), parent company of Centennial Bank, (“Centennial”), today announced that it has completed the purchase of the performing marine loan …

Synopsis :  A new variant of HIV was recently discovered in Europe. The new variant is more contagious, and it also is more deadly—the virus degrades the immune system into …

Synopsis: The U.S. Food and Drug Administration announced it is investigating a possible death risk for TG Therapeutics’ Ukoniq (umbralisib). The drug is indicated for two types of lymphoma. The …

Summary : The U.S. Food and Drug Administration approved Sanofi’s proposed drug to address red blood cell destruction in patients living with a rare form of anemia called cold agglutinin …

SUMMARY – Last year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by the name of Cabenuva was regarded as a peerless achievement since it eradicated …

Keypoints- Scientists are now tracking 2 which is the close cousin of highly transmissible BA.1beginning to spread across Asia and Europe. 2 cases are on the rise in Denmark, accounting …

Summary : Critically ill COVID-19 patients on a mechanical ventilator or extracorporeal membrane oxygenation (ECMO) lived more often when randomized to receive baricitinib. Doctors call this drug ‘bari,’ and receiving …

Summary – – Tiziana is Developing the First Oral Form of Foralumab in a Convenient Capsule to be Evaluated in Phase 1b Clinical Study Tiziana Life Sciences Ltd (Nasdaq: TLSA) …

Summary : Liver cancer, also known as hepatic cancer and primary hepatic cancer, is a relatively rare form of cancer that has a high mortality rate. As with other cancers, …

Synopsis : mdgroup, the leading global provider of personalised clinical study services, has appointed Dr Arthur Lazarus as Medical Director. Dr Lazarus will also be speaking at SCOPE 2022 on …

Summary : Fast Radius will trade on Nasdaq under ticker symbol “FSRD” “Fast Radius”), a cloud manufacturing company, today announced the successful closing of its previously announced business combination with …

Synopsis : ION Geophysical Corporation (NYSE: IO) today announced that it received notice on January 31, 2022 from the New York Stock Exchange (the “NYSE”) that the price of its …

Summary : FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Enjaymo is the only approved treatment to decrease the need for red blood cell …

Synopsis : Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced the grant to two employees …

Synopsis : Sanofi has been a global healthcare leader that has brought forth treatments for rare diseases and established standard-of-care therapeutics for areas such as diabetes and cardiovascular diseases. After …

Synopsis : Novartis reported its full-year financials this week for 2021, and overall, the news was good. Full-year net sales grew 4%, fourth-quarter sales were up 6% and operating income …

Summary – The House Energy and Commerce Committee’s health panel met to discuss renewing user fee agreements used to fund the U.S. Food and Drug Administration. To many observers’ surprise, …

Synopsis : Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today reported further positive Phase 2 data for their Lyme disease vaccine …

Summary : Scientists from Ludwig-Maximilians-Universitaet (LMU) in Munich, Helmholtz Munich, and Technical University of Munich have shown that the immune system is capable of neutralizing even Omicron after a total …

Summary : Targa Resources Corp. (NYSE: TRGP) (“Targa” or the “Company”) announced today that it has executed agreements selling its wholly-owned subsidiary that holds a 25 percent equity interest in …

Summary : OceanFirst Financial Corp. (NASDAQ:”OCFC”), (the “Company”), the holding company for OceanFirst Bank N.A. (the “Bank”), today, announced the Company has signed an agreement to acquire a majority interest in …

Summary : -As Australians gear up for the further reopening of international travel lanes in 2022, proof of COVID-19 vaccination is a necessity. -To provide this proof, Verizon Business Australia …

Global Crossing Airlines Group, Inc. (JET: TSX-V; JET.B: TSX-V; JETMF: OTCQB) (the “Company” or “GlobalX”) today announces that, on February 3, 2022 the Company filed a Form 8-A Registration Statement (“Form …

Summary : First-ever lentiviral hematopoietic stem cell gene therapy approved for reimbursement by NHS England Two children with early-onset MLD recently treated commercially with Libmeldy in Germany and France A …

Summary : On Thursday, Mersana Therapeutics signed a research and licensing deal with Janssen Biotech to access each other’s proprietary technology in discovering new antibody-drug conjugates (ADCs) for three cancer …

Synopsis : A $1.5 billion diabetes partnership between Eli Lilly and China-based Regor Therapeutics Group is at the center of a lawsuit filed by Pfizer, claiming that the founders of …

Synopsis : A new study published in the journal Nature found that two patients with leukemia who were treated with CAR T-cell therapy are still in remission 10 years later. …

Summary : Featuring nine of the most important regions in the life sciences industry, BioSpace’s Hotbed Maps are the guide employees and investors across the sector look to in order …

Summary : Amgen (NASDAQ:AMGN) and Plexium, Inc. (Plexium) today announced an exclusive, worldwide, multi-year research collaboration and license agreement to identify novel targeted protein degradation therapeutics toward historically challenging drug …

Summary :  A new option for those affected by keratoconjunctivitis sicca. The FDA approved the first generic of cyclosporine ophthalmic emulsion (Restasis) for dry eye, a condition that affects millions …

Summary : This week, Gilead Sciences took a $1.25 billion hit after reaching a settlement with ViiV Healthcare on a patent dispute involving the human immunodeficiency virus (HIV) drug dolutegravir. …